Clinical Trials Sponsored by Anapharm

Total 63 results

Par Pharmaceutical, Inc.
Anapharm

Completed

Bioavailability Study of Doxycycline Monohydrate Capsules and Monodox Under Fasting and Fed Conditions

To Determine Bioequivalence Under Fed Conditions

Canada
Endo Pharmaceuticals
SFBC Anapharm

Completed

Evaluating the Effect of Food on Absorption of Megace ES

Pharmacokinetics | Bioavailability | Absorption

Canada
Par Pharmaceutical, Inc.
Anapharm

Completed

Bioequivalence Study of Doxycycline Monohydrate Tablets Under Fasting Conditions

To Determine Bioequivalence Under Fasting Conditions

Canada
Par Pharmaceutical, Inc.
Anapharm

Completed

Bioavailability Study of Torsemide Tablets Under Fasting Conditions

To Determine Bioequivalence Under Fasting Conditions
Par Pharmaceutical, Inc.
Anapharm

Completed

Bioequivalence Study Doxycycline Tablets and Monodox Capsules Under Fasting Conditions

To Determine Bioequivalence Under Fasting Conditions

Canada
Par Pharmaceutical, Inc.
Anapharm

Completed

Bioequivalence Study of Cabergoline Tablets and Dostinex Under Fasting Conditions

To Determine Bioequivalence Under Fasting Conditions

Canada
Par Pharmaceutical, Inc.
Anapharm

Completed

Bioequivalence Study of Doxycycline Monohydrate Tablets Under Fed Conditions

To Determine Bioequivalence Under Fed Conditions

Canada
Par Pharmaceutical, Inc.
Anapharm

Completed

Bioequivalence Study of Cabergoline Tablets and Dostinex Under Fed Conditions

To Determine Bioequivalence Under Fed Conditions

Canada
Ionis Pharmaceuticals, Inc.
Anapharm

Completed

Safety and Tolerability of Single and Multiple Doses of ISIS 353512 in Healthy Volunteers

Inflammatory Diseases

Canada
Par Pharmaceutical, Inc.
Anapharm

Completed

Bioavailability Study of Torsemide Tablets Under Fed Conditions

Healthy
Par Pharmaceutical, Inc.
Anapharm

Completed

Bioavailability Study of Doxycycline Monohydrate Capsules and Monodox Under Fasting Conditions

To Determine Bioequivalence Under Fasting Conditions

Canada
Par Pharmaceutical, Inc.
SFBC Anapharm

Completed

Bioavailability Study of Propranolol Under Fasting Conditions

To Determine Bioequivalence Under Fasting Conditions

Canada
Darnitsa Pharmaceutical Company
Anapharm Bioanalytics

Completed

Bioequivalence Study of Test and Reference 120 mg Etoricoxib Film-coated Tablets in Healthy Volunteers

Healthy Subjects | Bioequivalence

Turkey
Par Pharmaceutical, Inc.
SFBC Anapharm

Completed

Bioavailability Study of Propranolol Under Fed Conditions

To Determine Bioequivalence Under Fed Conditions
MinaPharm Pharmaceuticals

Recruiting

Study to Assess the Safety & Efficacy of Oral Ciprodiazole Versus Currently Used Ciprofloxacin & Metronidazole (CIPRO-001)

Surgical Site Infections

Egypt
InQpharm Group

Completed

Efficacy and Safety of Glucosanol™ in Body Weight Reduction

Overweight and Obesity

Germany
InQpharm Group

Withdrawn

Tolerability and Benefit of IQP-AS-121 on Fatigue and Mental Alertness

Fatigue

Germany
InQpharm Group

Completed

Clinical Benefit of a Mouthrinse for the Treatment of Dentine Hypersensitivity

Dentin Sensitivity

Germany
InQpharm Group

Completed

Benefit and Tolerability of IQP-AE-103 in Weight Loss

Obesity | Overweight

Germany
InQpharm Group

Completed

Efficacy and Safety of IQP-AK-102 in Reducing Appetite

Appetite Regulation | Energy Intake | Appetite Suppression

Germany
MinaPharm Pharmaceuticals

Unknown

Gonapure® in Multifollicular Stimulation in Egyptian Women Undergoing IVF/ICSI (GIVF)

Female Infertility

Egypt
InQpharm Group

Completed

Efficacy and Safety of Glucosanol in Maintaining Body Weight

Obesity | Overweight

Germany
InQpharm Group

Completed

Safety and Efficacy of Litramine in Overweight and Obese Subjects

Obesity | Overweight | Weight Loss

Germany
InQpharm Group

Completed

Benefit and Tolerability of IQP-LU-104 in Weight Loss

Obesity | Overweight

Germany
InQpharm Group

Completed

Safety and Efficacy of IQP-MM-101 in Reducing Symptoms of Diarrhoea

Diarrhoea

Germany
InQpharm Group

Completed

Efficacy and Safety of Litramine in 1 Year Weight Loss Study

Weight Loss | Overweight and Obesity | Obesity; Excess Calories

Germany
InQpharm Group

Completed

Influence of IQPAS-119 on Post-Marathon Susceptibility to Infections and Others

Upper Respiratory Tract Symptoms

Germany
InQpharm Group

Completed

Efficacy and Safety of IQP-VV-102 in Weight Management

Obesity | Overweight

Germany
InQpharm Group

Completed

Litramine in Weight Maintenance

Overweight | Obese | Weight Maintenance

Germany
InQpharm Group

Completed

IQP-CL-101 in IBS Management

Irritable Bowel Syndrome

Germany
InQpharm Group

Completed

IQP-PO-101 for the Regulation of Bowel Movement Frequency

Constipation | Irregular Bowel Movement Frequency

Germany
Unipharm, Inc.

Completed

Efficacy and Safety of ARTRA (Glucosamine Plus Chondroitin Sulfate Combination) in Treatment of Chronic Low Back Pain

Low Back Pain

Russian Federation
InQpharm Group

Completed

Safety and Efficacy of IQP-LH-101 in Postprandial Heartburn

Postprandial Heartburn

Germany
Nuvamid SA
Medpace, Inc.; Anapharm; LGD

Active, not recruiting

Study of the Safety, Tolerability, and Pharmacokinetics of NUV001 Administered Orally to Healthy Adult Participants

Healthy Volunteers

United States
MinaPharm Pharmaceuticals

Recruiting

Study to Compare the Efficacy & Safety of Ursoplus Capsules vs. UDCA vs. Placebo Among Chronic Liver Disease Patients (URSO-003)

Chronic Liver Disease

Egypt
MinaPharm Pharmaceuticals

Recruiting

Study Evaluation of Recombinant Hirudin in Prophylaxis of Post-Operative Deep Vein Thrombosis (Thromb-001)

Prophylaxis of Deep Vein Thrombosis

Egypt
InQpharm Group

Withdrawn

Vasoactive Effects of IQP-AS-118 in Healthy Individuals

Cardiovascular Disease | Blood Flow

Germany
InQpharm Group

Completed

Benefit of IQP-AS-118 on Blood Pressure and LDL-cholesterol

Blood Pressure | Low Density Lipoprotein Cholesterol Level

Germany
InQpharm Group

Completed

Efficacy of Glucosanol™ in Reducing Post-prandial Glucose Levels in Overweight Subjects

Hyperglycemia, Postprandial

Germany
InQpharm Group

Completed

Safety and Efficacy of IQP- AK-102 in Reducing Body Weight

Weight Loss

Germany
InQpharm Group

Terminated

Benefit and Tolerability of IQP-AS-105 in Reducing Susceptibility to Upper Respiratory Tract Infections

Common Cold | Upper Respiratory Tract Infections

Germany
InQpharm Group

Completed

Benefit of IQP-VV-102 in Reducing Postprandial Glucose Level in Overweight Caucasian Subjects

Hyperglycemia | Prediabetes

Germany
InQpharm Group

Completed

Litramine for Weight Loss

Weight Loss
InQpharm Group

Completed

Efficacy and Safety of Zenoctil in Reducing Body Weight

Overweight

Germany
InQpharm Group

Completed

Safety and Efficacy of IQP-AK-102 in Reducing Appetite

Weight Loss | Appetite Modulation (Focus of Study)

Germany
MinaPharm Pharmaceuticals

Unknown

Topical r-Hirudin ( Thrombexx ) Efficacy in Treatment of Haematomas

r-Hirudin (Thrombexx) Efficacy in Treatment of Haematomas

Egypt
InQpharm Group

Completed

Safety and Efficacy of Glucosanol in Reducing Body Weight in Overweight and Obese Subjects

Overweight and Obesity

Germany
MinaPharm Pharmaceuticals

Unknown

Trial Comparing the Efficacy, Tolerability and Safety Between Three Arms in Treatment of HCV in Egyptian Population (Quadritherapy)

Chronic Hepatitis c

Egypt
MinaPharm Pharmaceuticals

Unknown

Hansenula-derived Pegylated Interferon in Treatment of Patients With Chronic Hepatitis C (HAPIC)

Chronic Hepatitis C

Egypt
InQpharm Group

Completed

Nasya in Allergic Rhinitis

Allergic Rhinitis

Germany

Clinical Trials Sponsored by Anapharm

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Czech Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations